Recent

% | $
Quotes you view appear here for quick access.

Amgen Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • balhara balhara Aug 13, 2009 4:59 PM Flag

    Dmab approved for prostate cancer related bone loss

    the drug is approved for (1) treatment of osteoporosis and (2) treatment of bone loss in prostate cancer

    it is rejected for (1) prevention of osteoporosis (2) prevention of bones loss in prostate cancer (3) prevention of bone loss in breast cancer and (4) treatment of bone loss in breast cancer.

 
AMGN
145.04-4.87(-3.25%)Feb 5 4:00 PMEST